As of 2024-12-14, the Intrinsic Value of Neoleukin Therapeutics Inc (NLTX) is
-18.23 USD. This NLTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 3.49 USD, the upside of Neoleukin Therapeutics Inc is
-622.31%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-18.23 USD
Intrinsic Value
NLTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-18.23 - -18.23 |
-18.23 |
-622.31% |
| P/E |
(62.34) - (63.80) |
(53.32) |
-1627.8% |
| DDM - Stable |
(24.85) - (67.22) |
(46.03) |
-1419.1% |
| DDM - Multi |
(37.94) - (80.88) |
(51.76) |
-1583.2% |
NLTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
32.81 |
| Beta |
-0.35 |
| Outstanding shares (mil) |
9.40 |
| Enterprise Value (mil) |
7.61 |
| Market risk premium |
5.00% |
| Cost of Equity |
11.58% |
| Cost of Debt |
5.00% |
| WACC |
11.48% |